Cited by 20Radiation Therapy and DosimetryAdvanced Radiotherapy TechniquesNanoplatforms for cancer theranostics

Hollow Gold Nanoparticles as Efficient In Vivo Radiosensitizing Agents for Radiation Therapy of Breast Cancer

Mulgaonkar, Aditi, Moeendarbari, Sina, Silvers, William, Hassan, Gedaa, Sun, Xiankai, Hao, Yaowu, Mao, Weihua·2017·Journal of Biomedical Nanotechnology

Integrity signals

Registry

Crossref · 10.1166/jbn.2017.2367

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • High-Z nanoplatforms based on silver, gadolinium, platinum, gold, and bismuth enhance radiation-induced energy deposition through photoelectric interactions and secondary electron generation.

    “High-atomic-number (high-Z) nanoplatforms based on silver (Z = 47), gadolinium (Z = 64), platinum (Z = 78), gold (Z = 79), and bismuth (Z = 83) enhance radiation-induced energy deposition through photoelectric interactions and secondary electron generation [15,20,27,28,30,33,34,36,50,63].”
  • Combined treatment was associated with greater tumor growth delay or regression compared to radiotherapy alone.

    “Combined treatment was associated with greater tumor growth delay or regression compared to radiotherapy alone [17,20,39,40,43,50,63,80].”
  • While ROS amplification and DNA damage remain the most consistently reported foundational processes, nanoplatforms combining physical dose enhancement with biologically active components such as hypoxia-targeting systems, catalytic redox modulators, or immune-related approaches demonstrate more robust and sustained antitumor effects across preclinical models.

    “While ROS amplification and DNA damage remain the most consistently reported foundational processes [15,20,30,33,63], nanoplatforms combining physical dose enhancement with biologically active components, such as hypoxia-targeting systems, catalytic redox modulators, or immune-related approaches, demonstrate more robust and sustained antitumor effects across preclinical models [17,19,21,26,39,45,”
  • The earliest and most extensively investigated approach is conventional radiotherapy enhancement based on high-atomic-number nanomaterials, including gold, silver, platinum, bismuth, gadolinium, and hafnium-containing nanoparticles.

    “The earliest and most extensively investigated approach is conventional radiotherapy enhancement based on high-atomic-number (high-Z) nanomaterials, including gold, silver, platinum, bismuth, gadolinium, and hafnium-containing nanoparticles [15,20,27,28,30,33,34,36,50,63].”
  • Detailed dosimetric characterization was frequently lacking, reducing reproducibility and limiting radiobiological interpretation.

    “Radiation parameters were inconsistently reported, with considerable variability in total dose, fractionation schedules, beam energy, dose rate, and irradiation modality [15,20,24,30,52,63,74], while detailed dosimetric characterization was frequently lacking, reducing reproducibility and limiting radiobiological interpretation.”

Cited by

Sorted by citations

Authors
Mulgaonkar, A., Moeendarbari, S., Silvers, W., Hassan, G., Sun, X., Hao, Y., & Mao, W.
Venue
Journal of Biomedical Nanotechnology
Published
2017-05-01
Volume
13
Issue
5
Pages
566-574
ISSN
1550-7033 (ISSN-L)
OpenAlex
W2617867020
Cited by
20
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 1 · 2020: 2 · 2019: 4 · 2018: 2 · 2017: 2
FWCI
2.27
Type
journal article
Language
en
Open access
closed
Locations
Journal of Biomedical Nanotechnology (publishedVersion)
Funders
University of Texas at Arlington
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Radiation Therapy and Dosimetry
  • Physical Sciences › Physics and Astronomy › Radiation › Advanced Radiotherapy Techniques
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
Keywords
hollow gold nanoparticles, radiosensitizers, radiotherapy, breast cancer, in vivo drug delivery, gold nanoshells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review